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  SFmulants	  are	  the	  first	   line	  pharmacotherapy	  
for	   AKenFon	   Deficit	   HyperacFvity	   Disorder	  
(ADHD).	   The	   number	   of	   prescripFon	   for	  
sFmulants	   dispensed	   by	   retail	   pharmacies	   has	  
increased	  from	  4	  million	   in	  1991	  to	  45	  million	   in	  
2010	  (1).	  Adolescents	  have	  a	  lifeFme	  prevalence	  
of	   nonmedical	   use	   of	   sFmulants	   of	   9.1%	   (2).	  
Given	   the	   increased	   number	   and	   availability	   of	  
sFmulant	   pills	   and	   the	   potenFal	   for	  misuse	   and	  
diversion,	   it	   is	   important	   for	   prescribers	   to	  
carefully	   assess	   sFmulant	  misuse	   in	   adolescents	  
with	  ADHD.	  	  	  
	   	   	   One	   study	   of	   physician’s	   percepFons	   about	  
s Fmu l a n t	   m i s u s e	   n o t e d	   t h a t	   m a n y	  
physicians	  were	  unaware	  of	  these	  issues	  (3).	  The	  
a i m s 	   o f 	   t h i s 	   s u r v e y 	   w e r e 	   t o	  
assess	  pediatric	  psychiatry	  and	  pediatric	  primary	  
care	   clinicians'	   knowledge	   of	   and	   screening	  
pracFces	   for	   sFmulant	   misuse	   in	   adolescents	  
with	   ADHD.	   	   We	   also	   assessed	   interest	   in	  
a	   possible	   screening	   aid	   such	   as	   a	   best	   pracFce	  
alert	  in	  the	  Electronic	  Medical	  Record	  (EMR).	  	  
	  
	   	   	   A	   brief	   survey	   was	   developed	   to	   assess	  
clinicians'	   knowledge	  and	  clinical	  pracFce.	  Three	  
quesFons	   gathered	   demographics	   informaFon	  
such	  as	  clinic	  locaFon	  and	  size	  of	  caseload.	   	  Four	  
mulFple-­‐choice	   quesFons	   were	   used	   to	   assess	  
providers’	   knowledge	   about	   sFmulant	  misuse	   in	  
the	   United	   States.	   Ten	   quesFons	   assessed	  
clinicians’	   current	   pracFces	   with	   adolescent	  
paFents	  with	  ADHD.	  Two	  quesFons	  pertained	  to	  
interest	   in	   a	  best	   pracFce	  alert	   in	   the	  EMR.	   The	  
survey	   was	   presented	   to	   and	   reviewed	   by	   the	  
Quality	   Improvement	   CommiKee	   of	   the	  
Department	   of	   Child	   and	   Adolescent	   Psychiatry	  
and	  Behavioral	  Sciences.	  	  
	   	   	   	  The	  survey	  was	  sent	  to	  130	  CHOP	  providers	  at	  
suburban	   and	   urban	   locaFons	   over	   a	   one-­‐week	  











This	  study	  was	  limited	  to	  30	  par,cipants	  exclusively	  at	  Children’s	  Hospital	  of	  Philadelphia.	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Clinicians’	  Prac,ce	  
74.9%	  of	  clinicians	  screen	  their	  adolescent	  paFent	  for	  
sFmulant	  misuse.	  On	  a	  scale	  of	  1	  (not	  a	  problem)	  to	  10	  
(a	  large	  problem,	  on	  average,	  clinicians	  rate	  sFmulant	  
misuse	  in	  the	  adolescents	  with	  ADHD	  that	  they	  treat	  as	  
a	  3	  (a	  minor	  problem).	  	  
Results	  
Percentage	  of	  Adolescent	  Pa,ents	  with	  ADHD	  Suspected	  of	  




Clinicians	  have	  varying	  degrees	  of	  concern	  for	  what	  percentage	  of	  their	  
paFents	  are	  misusing	  sFmulant	  medicaFon,	  with	  39%	  believing	  0%	  are	  
misusing	  their	  medicaFon	  and	  58%	  believing	  1-­‐3%	  are	  misusing	  their	  
medicaFon.	  Only	  4%	  of	  clinicians	  believe	  4-­‐7%	  of	  their	  paFents	  are	  
misusing	  sFmulant	  medicaFons.	  	  
Clinicians	  talk	  to	  their	  paFents	  at	  varying	  Fme	  about	  sFmulant	  misuse-­‐	  
with	  77%	  discussing	  sFmulant	  misuse	  at	  their	  iniFal	  evaluaFon;	  73%	  
discuss	  misuse	  when	  they	  suspect	  their	  paFents	  are	  misusing	  
sFmulants;	  58%	  of	  clinicians	  discuss	  sFmulant	  misuse	  when	  they	  
suspect	  substance	  abuse.	  	  
Clinicians	  discuss	  varying	  topics	  when	  addressing	  sFmulant	  misuse	  
with	  84%	  discussing	  parental	  monitoring	  and	  administraFon.	  Only	  
19%	  of	  clinicians	  surveyed	  discuss	  refusal	  skills	  or	  provide	  guidance	  to	  
paFents	  about	  being	  approached	  to	  sell,	  trade,	  or	  give	  away	  their	  
medicaFon.	  	  
Which	  of	  the	  following	  topics	  do	  you	  review	  with	  your	  pa,ents	  and	  
their	  parents	  when	  discussing	  s,mulant	  use?	  (Check	  all	  that	  apply.)	  
Answer	  Op,ons	   Response	  Percent	  
Parental	  monitoring	  and	  administraFon	  of	  medicaFon	  
84.6%	  
Abuse	  potenFal	   69.2%	  
Safe	  storage	   65.4%	  
Legal	  ramificaFons	  of	  sharing,	  trading,	  or	  selling	  medicaFons	   50.0%	  
Medical	  consequences	  of	  sFmulant	  misuse	   46.2%	  
Refusal	  skills	  and/or	  guidance	  about	  requests	  from	  peers	  to	  share,	  
trade,	  or	  sell	  medicaFons	  
19.2%	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Ques,on	  1-­‐	  What	  is	  the	  prevalence	  of	  sFmulant	  
misuse	  in	  the	  past	  12	  months	  among	  12-­‐18	  year	  olds	  
in	  the	  US?	  33%	  chose	  the	  correct	  answer	  which	  was	  
5-­‐10%.	  
Ques,on	  2-­‐	  	  What	  percentage	  of	  adolescents	  
prescribed	  sFmulants	  are	  asked	  to	  sell,	  trade,	  or	  give	  
away	  their	  medicaFons?	  51.9%	  chose	  the	  correct	  
answer	  which	  was	  15-­‐30%.	  
Ques,on	  3-­‐	  What	  sFmulants	  are	  misused	  most	  onen?	  
85.2%	  chose	  the	  correct	  answer	  which	  was	  
Amphetamine	  deriva=ves	  immediate	  release	  (i.e.,	  
































Clinician	  Knowledge	  on	  S,mulant	  Misuse	  
Most	  clinicians	  screen	  their	  paFents	  for	  sFmulant	  misuse	  
by	  direct	  quesFoning.	  Other	  screening	  techniques	  
clinicians	  listed	  include	  calling	  the	  pharmacy,	  reviewing	  
the	  number	  of	  prescripFons	  given	  and	  frequency	  of	  
“lost”	  prescripFons,	  and	  noFng	  requests	  for	  early	  refills.	  	  
	  
Percentage	  of	  Clinicians	  who	  Screen	  for	  
S,mulant	  Misuse	  	  
Yes	   No	  
Results	  
Demographics	  
•  63%	   of	   respondents	   were	   psychiatry	  
aKendings,	  fellows,	  or	  nurse	  pracFFoners.	  	  
•  Nearly	  all	  pracFced	  in	  urban	  serng.	  	  
•  Majority	   of	   respondents	   (75.8%)	   indicated	  
that	  they	  prescribed	  sFmulants	  for	  between	  






If	  so,	  how	  do	  you	  screen	  for	  s,mulant	  misuse?	  (Check	  
all	  that	  apply).	  Response	  Percent	  
Verbal	  quesFoning	  
































































































































































































IniFal	  EvaluaFon/IniFal	  PrescripFon	  When	  you	  suspect	  sFmulant	  misuse	  (ie:	  missing	  or	  stolen	  
medicaFons	  or	  prescripFons,	  early	  refill	  requests)	  
When	  you	  suspect	  substance	  abu e	  (tobacc ,	  marijuana,	  alcohol,	  
prescripFon	  dr g )	  
When	  Fme	   llows	  /	  No	  set	  p Kern	  Other	  ( lease	  specify)	  Eve y	  m dic F n	  managment	  appointment	  or	  sick	  visit	  A nual	  Exam	  Wh 	  the	  paFent	  turns	  12	  years	  old	  
Timing	  of	  Discussions	  of	  S,mulant	  Misuse	  
0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
Would	  you	  find	  a	  best	  pracFce	  alert	  
embedded	  into	  an	  electronic	  medical	  record	  
a	  helpful	  reminder	  to	  screen	  for	  sFmulant	  
misuse?	  
Would	  you	  find	  a	  best	  pracFce	  alert	  
embedded	  in	  an	  electronic	  medical	  record	  a	  
helpful	  reminder	  to	  discuss	  issues	  about	  
sFmulant	  misuse	  and	  diversion?	  
Helpfulness	  Ranking	  of	  Best	  Prac,ce	  Alerts	  	  
•  Clinicians	  are	  knowledgeable	  about	  sFmulant	  misuse.	  
o  The	  vast	  majority	  of	  the	  clinicians	  surveyed	  are	  aware	  
that	  immediate	  release	  amphetamines	  are	  most	  onen	  
misused.	  This	  knowledge	  is	  reflected	  in	  providers’	  
prescribing	  habits.	  Over	  75	  %	  of	  clinicians	  surveyed	  
report	  prescribing	  extended	  release	  formulaFons	  	  
o  Clinicians	  are	  less	  knowledgeable	  about	  the	  prevalence	  
of	  sFmulant	  misuse	  and	  diversion.	  Given	  that	  25%	  of	  
adolescents	  who	  are	  prescribed	  sFmulants	  are	  
approached	  to	  sell,	  trade,	  or	  give	  away	  their	  
medicaFon	  (4),	  it	  important	  that	  clinicians	  review	  the	  
medical	  and	  legal	  consequences	  of	  sharing	  medicaFons	  
with	  their	  paFents.	  Among	  surveyed	  providers,	  few	  
(19%)	  discussed	  refusal	  skills	  with	  their	  paFents.	  More	  
clinicians	  should	  consider	  discussing	  tacFcs	  that	  teens	  
can	  use	  if	  approached	  to	  share	  or	  sell	  their	  
medicaFons.	  	  
•  The	  majority	  of	  providers	  screen	  their	  paFents	  for	  
sFmulant	  misuse.	  
o  Most	  clinicians	  surveyed	  discuss	  issues	  pertaining	  to	  
sFmulant	  misuse	  during	  the	  iniFal	  evaluaFon	  or	  when	  a	  
sFmulant	  is	  first	  prescribed.	  	  These	  issues	  should	  be	  
reviewed	  periodically	  as	  the	  paFent	  matures.	  	  
•  Providers’	  concerns	  about	  sFmulant	  misuse	  in	  the	  
paFents	  that	  they	  treat	  correspond	  with	  naFonal	  trends.	  
o  Over	  50%	  of	  respondents	  suspected	  1-­‐3%	  of	  paFents	  
had	  misused	  sFmulants	  in	  the	  past	  year.	  These	  results	  
are	  similar	  results	  to	  a	  naFonal	  survey	  of	  pediatric	  
psychiatrists,	  pediatric	  neurologists,	  and	  
developmental	  pediatricians	  where	  59%	  of	  
respondents	  suspected	  that	  one	  or	  more	  paFents	  had	  
diverted	  sFmulants	  in	  the	  past	  year(3).	  
•  Some	  providers	  think	  a	  best	  pracFce	  alert	  in	  the	  
electronic	  medical	  record	  would	  be	  helpful.	  	  	  
Future	  DirecFons	  
•  To	  increase	  providers’	  knowledge	  about	  sFmulant	  
misuse,	  informaFon	  about	  sFmulant	  misuse	  could	  be	  
reviewed	  at	  noon	  meeFngs,	  lectures,	  or	  assigned	  
electronic	  learning	  modules.	  
•  To	  increase	  screening	  and	  discussions	  of	  sFmulant	  
misuse,	  a	  best	  pracFce	  alert	  could	  be	  included	  in	  the	  
EMR	  for	  adolescent	  paFents	  receiving	  sFmulants.	  
•  To	  address	  prescripFon	  drug	  abuse	  providers	  could	  
consistently	  use	  the	  PrescripFon	  Drug	  Monitoring	  
Database	  and	  encourage	  paFents	  and	  families	  to	  
properly	  dispose	  of	  their	  unused	  prescripFon	  
medicaFons.	  
Clinician’s	  Use	  of	  Long-­‐Ac,ng	  S,mulant	  Formula,ons	  
•  On	  a	  scale	  from	  1	  (never)	  to	  10	  always,	  clinicians	  
prescribed	  long	  acFng	  sFmulant	  formulaFons	  very	  
onen	  (8).	  	  
